SPDR® MSCI World Health Care UCITS ETF | WHEARegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 9.8 | 20.7 | 6.3 | -2.2 | 5.1 | |
+/-Cat | -7.7 | 11.3 | 11.0 | 0.9 | 3.1 | |
+/-B’mrk | - | 2.5 | 0.5 | 0.3 | 0.3 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
Closing Price 07/05/2024 | USD 61.05 | |
Day Change | 1.11% | |
Morningstar Category™ | Sector Equity Healthcare | |
Volume | 5373 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BYTRRB94 | |
Fund Size (Mil) 07/05/2024 | USD 571.10 | |
Share Class Size (Mil) 07/05/2024 | USD 571.10 | |
Ongoing Charge 27/10/2023 | 0.30% |
Investment Objective: SPDR® MSCI World Health Care UCITS ETF | WHEA |
The investment objective of the Fund is to track the performance of companies in the Health Care sector, across developed markets globally. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 29/04/2016 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World Health Care 35/20 Capped NR | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for SPDR® MSCI World Health Care UCITS ETF | WHEA | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 8.42 |
UnitedHealth Group Inc | Healthcare | 5.97 |
Novo Nordisk A/S Class B | Healthcare | 5.64 |
Johnson & Johnson | Healthcare | 4.65 |
Merck & Co Inc | Healthcare | 4.38 |
Increase Decrease New since last portfolio | ||
SPDR® MSCI World Health Care UCITS ETF | WHEA |